• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HU Meifang.Study on repeated dose toxicity of Qubai Babuqi Tablets in Rats treatd with intragastric administraction[J].Journal Of Pharmaceutical Research,2018,37(3):146-148,177[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3663times   Download 2820次 QR Code for this article
Scan with your phone!
大鼠灌胃驱白巴布期片重复给药毒性研究
胡美芳
Font:Larger+|Default|Smaller-
(山东胜利药业有限公司,山东 东营 257055)
摘要:
目的 研究大鼠灌胃给予驱白巴布期片13周重复给药的毒性。方法 选取SD大鼠120只,雌雄各半,分为溶媒对照组及驱白巴布期片1.5、3.0、6.0 g·kg-1 3个剂量组,每天给药1次,给药容积为10 mL·kg-1,连续给药13周,停药恢复4周。试验期间,每天进行一般状态观察,给药期及恢复期每周测定1次体重,给药结束取20只和恢复期结束取10只动物安乐死,进行血液学、血液生化学、脏器系数和病理组织学检查。结果 驱白巴布期片灌胃给药13周后,大鼠一般状态正常、血液学和血液生化学等指标与溶媒对照组相比无显著性差异(P>0.05),大鼠主要脏器系数均在正常范围内,病理组织学检查未见明显异常。结论 驱白巴布期片≤6 g·kg-1剂量下灌胃给予大鼠未见明显毒性反应,其最大无毒反应剂量(NOAEL)≥6 g·kg-1。
关键词:  驱白巴布期片  大鼠  重复给药毒性  安全性
DOI:10.13506/j.cnki.jpr.2018.03.005
基金项目:
Study on repeated dose toxicity of Qubai Babuqi Tablets in Rats treatd with intragastric administraction
HU Meifang
(Shandong Shenli Pharmaceutical Co.,Ltd.,,Dongying 257055,China)
Abstract:
Objective To observe the repeated dose toxicity of Qubai Babuqi Tablets to the rats that were fed with intragastric administration for 13 weeks.Methods 120 healthy SD rats,were divided into 4 groups:solvent control group,Qubai Babuqi Tablets for oral administration group(1.5,3.0,6.0 g·kg-1).The rats were administered intravenously with Qubai Babuqi Tablets for 13 weeks continuously.The body weights were detected every week and and recovery for 4 weeks.During the test,the general state of animals was observed daily,and all the animals should be weighed once a week in administration period and recovery period.At the end of the administration period and 4 weeks after drug withdrawal,animals were euthanized and carried out hematology,blood biochemistry, viscera index and histopathological examination.Results At the end of the administration period the general state of the rats in control groups were normal,there were no significant differences in hematology, and blood biochemistry(P>0.05).The viscera index of rat were in normal range,and histopathological examination showed no obvious abnormality.Conclusion No obvious toxic reaction was observed in the rats after given Qubai Babuqi Tablets with oral administration under the dosage of 6 g·kg-1, and the maximum non-toxic reaction dose (NOAEL) was greater than 6 g·kg-1.
Key words:  Qubai Babuqi Tablets  Rats  Repeated dose toxicity  Safety evaluation
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.